El. Gong et al., CONTRASTING IN-VIVO EFFECTS OF MURINE AND HUMAN APOLIPOPROTEIN A-II -ROLE OF MONOMER VERSUS DIMER, The Journal of biological chemistry, 271(11), 1996, pp. 5984-5987
The role of apolipoprotein A-II (apoA-II) in high density lipoprotein
(HDL) structure and metabolism has been studied previously in transgen
ic mice overexpressing either human or murine apoA-II. These studies h
ave shown differences between these two groups of transgenic animals i
n the levels of very low density, low density, and high density lipopr
oteins, in the HDL particle size distribution, and in the relationship
between apoA-II levels and lipoprotein levels. To determine whether t
hese differences are due to the fact that human apoA-II is dimeric and
murine apoA-II monomeric, me have examined the effects of monomeric h
uman apoA-II (hA-IImon) in transgenic mice. Site-directed mutagenesis
(Cys(6)-->Ser) was used to generate 15 transgenic founder lines of hA-
IImon mice, that contained plasma hA-IImon concentrations over a 10-fo
ld range (11 mg/dl to 185 mg/dl). The hA-IImon floated in the d less t
han or equal to 1.21 g/ml fraction and migrated as an apoA-II monomer
by nonreducing SDS-polyacrylamide gel electrophoresis. HDL levels were
not correlated with hA-IImon levels (r = 0.26); HDL particle size and
size distribution, as well as very low density and low density lipopr
otein levels and sizes, were unchanged compared to nontransgenic contr
ol mice. These results suggest that differences between mice overexpre
ssing human dimeric apoA-II and those overexpressing murine apoA-II ar
e the result of sequence differences between these two apoA-II: molecu
les and are not solely due to the fact that human apoA-II exists as a
dimer.